AtriCure Announces Initiation of the ABLATE Pivotal Trial to Evaluate …
Forbes - WEST CHESTER, Ohio, Feb. 11 /PRNewswire-FirstCall/ — AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in cardiac surgical ablation products, today announced that the first patient was successfully treated in AtriCure’s ABLATE …